The next board meeting for Protagonist Therapeutics Inc is on 09 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment ConferenceSee details
Protagonist Therapeutics Inc has a share price target of US$ 70, revenue growth forecast of -84.6%, and profit growth estimate of -146.1% for FY25, based on top 11 analyst calls.